{"id":"W2037395799","doi":"10.1111/dom.12226","title":"Composite endpoints in trials of type‐2 diabetes","year":2013,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Sitagliptin; Medicine; Saxagliptin; Type 2 diabetes; Exenatide; Linagliptin; Dapagliflozin; Liraglutide; Vildagliptin; Internal medicine; Diabetes mellitus; Clinical trial; Randomized controlled trial; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.04767252,0.002152759,0.01066812,0.0131929,0.0005923722,0.003652794,0.002285366,0.003067325,0.006328448],"category_scores_gemma":[0.08414989,0.001012716,0.006627967,0.01602305,0.001515758,0.002943627,0.002202891,0.003473065,0.000832618],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00312799,"about_ca_system_score_gemma":0.008001862,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001715433,"about_ca_topic_score_gemma":0.003431621,"domain_scores_codex":[0.9453537,0.03070124,0.01416069,0.002057724,0.007356539,0.0003702162],"domain_scores_gemma":[0.8629445,0.1125902,0.01746729,0.001774739,0.004632227,0.000591034],"domain_codex":null,"domain_gemma":"methods","domain_candidate":"methods","domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0003943801,0.00003486217,0.00036216,0.6806663,0.005612155,0.00005863614,0.0001517773,0.00021178,0.000221077,0.002496977,0.006173774,0.3036162],"study_design_scores_gemma":[0.001351302,0.0005711819,0.003984778,0.6982372,0.02550433,0.000529114,0.0002914496,0.0002665103,0.0004860946,0.007391118,0.2612794,0.0001075198],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00007454505,0.9986169,0.0003121119,0.0002239494,0.0001760222,0.0001935887,0.00008755462,0.000007768803,0.0003076531],"genre_scores_gemma":[0.002508766,0.9925697,0.002583906,0.0007545057,0.000215785,0.001012094,0.0002042709,0.00001143316,0.0001394772],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9523275,"threshold_uncertainty_score":0.2521194,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05628714280256385,"score_gpt":0.3221684609357011,"score_spread":0.2658813181331372,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}